To prevent further progression into secondary glaucoma, we actively applied topical drugs to alleviate the anterior chamber symptoms, treated the patient with anti-VEGF therapy, and performed retinal laser photocoagulation as soon as possible. The gene discussed is VEGFA; the disease is glaucoma.